Arcadia Biosciences, Inc. (RKDA) Stock Faces Higher Risks Forward After Forming Double Bottom Chart Pattern

February 15, 2018 - By Clifton Ray

The chart of Arcadia Biosciences, Inc. (RKDA) shows a double bottom with $4.65 target or 7.00 % below today’s $5.00 share price. The 7 months chart pattern indicates high risk for the $10.67 million company. It was reported on Feb, 15 by Finviz.com. If the $4.65 price target is reached, the company will be worth $746,970 less. Double bottoms are rare but powerful chart patterns.

The stock decreased 1.57% or $0.08 during the last trading session, reaching $5. About 6,360 shares traded. Arcadia Biosciences, Inc. (NASDAQ:RKDA) has declined 43.32% since February 15, 2017 and is downtrending. It has underperformed by 60.02% the S&P500.

Analysts await Arcadia Biosciences, Inc. (NASDAQ:RKDA) to report earnings on March, 14. They expect $-0.10 EPS, up 23.08 % or $0.03 from last year’s $-0.13 per share. After $-0.11 actual EPS reported by Arcadia Biosciences, Inc. for the previous quarter, Wall Street now forecasts -9.09 % EPS growth.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Ratings Coverage

Among 2 analysts covering Arcadia Biosciences (NASDAQ:RKDA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Arcadia Biosciences had 2 analyst reports since May 12, 2017 according to SRatingsIntel. Piper Jaffray maintained it with “Hold” rating and $100 target in Friday, July 21 report. The rating was downgraded by PiperJaffray to “Neutral” on Friday, May 12.

More notable recent Arcadia Biosciences, Inc. (NASDAQ:RKDA) news were published by: Bizjournals.com which released: “Arcadia Biosciences $65.6M IPO starts trading with revised price” on May 15, 2015, also Prnewswire.com with their article: “Morning Technical Insight on These Agricultural Chemicals Stocks — Arcadia …” published on January 24, 2018, Businesswire.com published: “Arcadia Biosciences Announces Passing of Board Chairman George Gosbee” on November 13, 2017. More interesting news about Arcadia Biosciences, Inc. (NASDAQ:RKDA) were released by: Businesswire.com and their article: “Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9” published on September 11, 2017 as well as Marketwatch.com‘s news article titled: “Arcadia Biosciences Inc.” with publication date: May 10, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.